All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Insilico Medicine advances AI drug for IPF to Phase III trials

By

Ryan Daws

17h agoen

Source

artificialintelligence-news.comInsilico Medicine advances AI drug for IPF to Phase III trialsartificialintelligence-news.com
Snippet from the RSS feed
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients […] The post Insilico Medicine advances AI drug for IPF to Phase III trials appeared first on AI News .

You might also wanna read

Large international study validates genetic risk score for diagnosing and predicting pulmonary fibrosis outcomes

Researchers have validated a polygenic risk score tool that can help diagnose idiopathic pulmonary fibrosis (IPF) and predict which patients

mayocl.in·9h ago

AI accelerates search for motor neurone disease treatments by repurposing existing drugs

Researchers are using AI to accelerate the search for drugs to treat motor neurone disease (MND). By repurposing existing approved drugs, th

bbc.co.uk·1mo ago

AI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuation

AI drug discovery startup Chai Discovery, founded just 15 months ago, released an antibody-designing AI model that generated intense interes

forbes.com·1mo ago

FDA's AI for Drug Approvals Found to Fabricate Studies

The FDA's AI system, designed to expedite drug approvals, has been discovered to generate fake studies and misrepresent research, raising co

The Onion·11mo ago

How AI Is Modernizing Clinical Trial Protocols for Smarter Drug Development

This article examines how artificial intelligence is being applied to modernize clinical trial protocols, which have remained largely static

medcitynews.com·29d ago

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design

The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse

drugtargetreview.com·5mo ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.